Language
English
Publication Date
5-19-2026
Journal
NPJ Vaccines
DOI
10.1038/s41541-026-01489-7
PMID
42156776
PMCID
PMC13454636
PubMedCentral® Posted Date
5-19-2026
PubMedCentral® Full Text Version
Post-print
Abstract
Although individuals with Down syndrome (DS) remain highly vulnerable to severe infections, vaccination remains underutilized. Here we review, specific to people with DS, the safety and efficacy of vaccination, drivers of susceptibility to infection, and existing and emerging opportunities to improve vaccine response. We find that vaccines are generally safe and immunogenic in individuals with DS, although continued research is essential to improve vaccine efficacy and health outcomes.
Keywords
Diseases, Health care, Immunology, Medical research
Published Open-Access
yes
Recommended Citation
Khor, Bernard; Spinazzi, Noemi A; Patel, Lina R; et al., "Vaccination in Individuals With Down Syndrome: Immune Vulnerability, Safety, Efficacy and Opportunities" (2026). Faculty, Staff and Students Publications. 8824.
https://digitalcommons.library.tmc.edu/baylor_docs/8824